|
1.
|
学術雑誌(原著)
|
Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers. 2021/03/15
|
|
2.
|
学術雑誌(総説)
|
Pre-existing interstitial lung disease does not affect prognosis in non-small cell lung cancer patients with PD-L1 expression ≥50% on first-line pembrolizumab. 2021/02
|
|
3.
|
学術雑誌(症例報告)
|
Detection of pseudoprogression with [ 18 F]-FDG-PET in a patient with pulmonary large cell neuroendocrine carcinoma who received anti-PD-1 treatment 2020/10/22
|
|
4.
|
学術雑誌(症例報告)
|
Osimertinib induced cardiomyopathy 2020/09/25
|
|
5.
|
学術雑誌(原著)
|
Tumor metabolic volume by 18F-FDG-PET as a prognostic predictor of first-line pembrolizumab for NSCLC patients with PD-L1 >/= 50 2020/09/14
|
|
6.
|
学術雑誌(原著)
|
Chemoradiotherapy followed by durvalumab in patients with unresectable advanced non-small cell lung cancer: Management of adverse events 2020/05/01
|
|
7.
|
学術雑誌(原著)
|
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer 2020/04/01
|
|
8.
|
学術雑誌(原著)
|
Potential of FDG-PET as Prognostic Significance after anti-PD-1 Antibody against Patients with Previously Treated Non-Small Cell Lung Cancer 2020/03/07
|
|
9.
|
学術雑誌(症例報告)
|
Psuedoprogression mimicking hyperprogressive disease after pembrolizumab treatment in a patient with lung cancer 2020/01
|
|
10.
|
学術雑誌(症例報告)
|
Unexpected response of extramedullary plasmacytoma in patients with lung cancer who received nivolumab 2019/12/01
|
|
11.
|
学術雑誌(原著)
|
Clinical difference between discontinuation and retreatment with nivolumab after immune-related adverse events in patients with lung cancer 2019/10
|
|
12.
|
学術雑誌(原著)
|
Re-challenge of afatinib after 1st generation EGFR-TKI failure in patients with previously treated non-small cell lung cancer harboring EGFR mutation 2019/05
|
|
13.
|
学術雑誌(原著)
|
Clinical significance of primary prophylactic pegylated-granulocyte-colony stimulating factor after the administration of ramucirumab plus docetaxel in patients with previously treated non-small cell lung cancer 2019/04
|
|
14.
|
学術雑誌(原著)
|
Different incidence of interstitial lung disease according to different kinds of EGFR-tyrosine kinase inhibitors administered immediately before and/or after anti-PD-1 antibodies in lung cancer 2019/04
|
|
15.
|
学術雑誌(原著)
|
Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non-small cell lung cancer patients 2019/04
|
|
16.
|
学術雑誌(総説)
|
特発性肺線維症(IPF)と喫煙 2012/09
|
|
17.
|
学術雑誌(原著)
|
15歳で発見された高分化胎児型腺癌の1例 2011/10
|
|
18.
|
学術雑誌(原著)
|
吸入ステロイドが著効した挿管後気管狭窄の1例 2010/09
|
|
19.
|
学術雑誌(総説)
|
【治療の優先順位はこうつける!】心疾患合併のCOPD β遮断薬をやめる?続ける? 2008/09
|
|
5件表示
|
|
全件表示(19件)
|
